Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Elastic
ESTC
|
+$348M |
| 2 |
Mercado Libre
MELI
|
+$296M |
| 3 |
Nu Holdings
NU
|
+$254M |
| 4 |
Roblox
RBLX
|
+$219M |
| 5 |
Shopify
SHOP
|
+$201M |
Top Sells
| 1 |
Albemarle
ALB
|
+$185M |
| 2 |
Illumina
ILMN
|
+$176M |
| 3 |
Li Auto
LI
|
+$162M |
| 4 |
Trade Desk
TTD
|
+$145M |
| 5 |
Ferrari
RACE
|
+$138M |
Sector Composition
| 1 | Consumer Discretionary | 29% |
| 2 | Healthcare | 24.31% |
| 3 | Technology | 17.32% |
| 4 | Communication Services | 11.22% |
| 5 | Financials | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Globus Medical
GMED
$8.04B
| $3.82M | ﹤0.01% |
64,077
| – | – |
|
252
Texas Instruments
TXN
$169B
| $3.72M | ﹤0.01% |
24,059
| – | – |
|
|
SAGE
253
DELISTED
Sage Therapeutics
SAGE
| $3.58M | ﹤0.01% |
91,395
+2,949
| +3% | +$116K |
|
254
Alector
ALEC
$279M
| $3.52M | ﹤0.01% |
371,837
+17,345
| +5% | +$164K |
|
255
HUTCHMED
HCM
$2.77B
| $3.45M | ﹤0.01% |
389,818
+24,839
| +7% | +$220K |
|
256
GitLab
GTLB
$7.99B
| $3.31M | ﹤0.01% |
64,583
-19,732
| -23% | -$1.01M |
|
|
MTLS
257
Materialise
MTLS
$307M
| $2.87M | ﹤0.01% |
268,000
| – | – |
|
258
CarMax
KMX
$9.21B
| $2.78M | ﹤0.01% |
42,148
-2,449
| -5% | -$162K |
|
|
API
259
Agora
API
$334M
| $2.7M | ﹤0.01% |
744,300
| – | – |
|
260
Adicet Bio
ACET
$63.5M
| $2.58M | ﹤0.01% |
181,626
| – | – |
|
|
RUBY
261
DELISTED
Rubius Therapeutics, Inc
RUBY
| $2.11M | ﹤0.01% |
4,853,773
-52,305
| -1% | -$22.7K |
|
|
CLLS
262
Cellectis
CLLS
$275M
| $1.81M | ﹤0.01% |
788,837
-92,095
| -10% | -$211K |
|
263
Golub Capital BDC
GBDC
$3.95B
| $1.51M | ﹤0.01% |
122,100
| – | – |
|
264
Transmedics
TMDX
$3.6B
| $1.47M | ﹤0.01% |
35,271
+1,544
| +5% | +$64.5K |
|
265
MaxCyte
MXCT
$150M
| $1.31M | ﹤0.01% |
+202,800
| New | +$1.31M |
|
266
Sixth Street Specialty
TSLX
$2.33B
| $1.3M | ﹤0.01% |
79,500
| – | – |
|
267
Agnico Eagle Mines
AEM
$77.5B
| $1.12M | ﹤0.01% |
26,423
+23,023
| +677% | +$972K |
|
268
Newmont
NEM
$83.2B
| $1.09M | ﹤0.01% |
25,959
+3,172
| +14% | +$133K |
|
269
WEC Energy
WEC
$34.6B
| $1.02M | ﹤0.01% |
11,353
-7,643
| -40% | -$683K |
|
270
Spire Global
SPIR
$278M
| $935K | ﹤0.01% |
108,256
| – | – |
|
271
Novanta
NOVT
$4.16B
| $918K | ﹤0.01% |
7,938
+352
| +5% | +$40.7K |
|
272
Exelon
EXC
$43.4B
| $856K | ﹤0.01% |
22,861
-5,591
| -20% | -$209K |
|
273
Ameren
AEE
$27B
| $837K | ﹤0.01% |
10,390
-2,541
| -20% | -$205K |
|
274
American Tower
AMT
$90.7B
| $835K | ﹤0.01% |
3,890
+326
| +9% | +$70K |
|
275
Xencor
XNCR
$600M
| $833K | ﹤0.01% |
32,055
+1,398
| +5% | +$36.3K |
|